In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Sussman, Daniel A ^a   Santaolalla, Rebeca ^a   Bejarano, Pablo A ^b   Garcia Buitrago, Monica T ^a   Perez, Maria T ^c   Abreu, Maria T ^a   Clarke, Jennifer ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c JFK Medical Center   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Bioinformatics; Colon cancer; Colorectal cancer; Immunohistochemistry; TLR4; Transcriptome

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN; TOLL LIKE RECEPTOR 4;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLON ADENOMA; COLON CANCER; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EX VIVO STUDY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MYOFIBROBLAST; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY;

COLORECTAL NEOPLASMS; EPITHELIUM; GENE EXPRESSION PROFILING; HUMANS; MICROSATELLITE INSTABILITY; MYOFIBROBLASTS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; TISSUE ARRAY ANALYSIS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTOME;

EID: 84902319520     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-33-45     Document Type: Article

References (46)

1. Inflammation and colon cancer. Terzic J, Grivennikov S, Karin E, Karin M, Gastroenterology 2010 138 6 2101 2114 e2105 10.1053/j.gastro.2010.01.058 20420949
2. Diversity of the human intestinal microbial flora. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA, Science 2005 308 5728 1635 1638 10.1126/science.1110591 15831718
3. Epithelial crosstalk at the microbiota-mucosal interface. Wells JM, Rossi O, Meijerink M, van Baarlen P, Proc Natl Acad Sci U S A 2011 108 Suppl 1 4607 4614 20826446
4. The mucosal anaerobic gram-negative bacteria of the human colon. Poxton IR, Brown R, Sawyerr A, Ferguson A, Clin Infect Dis 1997 25 Suppl 2 111 S113 9310645
5. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid. Zheng L, Riehl TE, Stenson WF, Gastroenterology 2009 137 6 2041 2051 10.1053/j.gastro.2009.08.055 19732774
6. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J, J Leukoc Biol 2009 86 3 557 566 10.1189/jlb.1008647 19451397
7. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, Itzkowitz SH, Abreu MT, Gastroenterology 2007 133 6 1869 1881 10.1053/j.gastro.2007.09.008 18054559
8. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, España C, Ungaro R, Harpaz N, Cooper HS, Elson G, Kosco-Vilbois M, Zaias J, Perez MT, Mayer L, Vamadevan AS, Lira SA, Abreu MT, Inflamm Bowel Dis 2011 17 7 1464 1473 10.1002/ibd.21527 21674704
9. TLR4 activates the beta-catenin pathway to cause intestinal neoplasia. Santaolalla R, Sussman DA, Ruiz JR, Davies JM, Pastorini C, España CL, Sotolongo J, Burlingame O, Bejarano PA, Philip S, Ahmed MM, Ko J, Dirisina R, Barrett TA, Shang L, Lira SA, Fukata M, Abreu MT, PLoS ONE 2013 8 5 63298 10.1371/journal.pone.0063298 23691015
10. Gene expression omnibus. http://www.ncbi.nlm.nih.gov/geo/
11. Colon cancer tissue microarray case sets. http://dctd.cancer.gov/ ProgramPages/cdp/tools-disease-specific.htm
12. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T, Br J Cancer 2010 102 5 908 915 10.1038/sj.bjc.6605558 20145615
13. The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, Garlanda C, Laghi L, Barberis MC, Sessa F, Noonan DM, Albini A, J Transl Med 2010 8 112 10.1186/1479-5876-8-112 21059221
14. RDCTeam, R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing 2010
15. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J Roy Stat Soc B Met 1995 57 1 289 300
16. Nonparametric methods for identifying differentially expressed genes in microarray data. Troyanskaya OG, Garber ME, Brown PO, Botstein D, Altman RB, Bioinformatics (Oxford, England) 2002 18 11 1454 1461 10.1093/bioinformatics/18. 11.1454
17. Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai J, Kerr D, Aaltonen LA, Arango D, Kruhøffer M, Orntoft TF, Andersen CL, Gruidl M, Kamath VP, Eschrich S, Yeatman TJ, Sieber OM, Clin Cancer Res 2009 15 24 7642 7651 10.1158/1078-0432. CCR-09-1431 19996206
18. Transcriptome profile of human colorectal adenomas. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G, Mol Cancer Res 2007 5 12 1263 1275 10.1158/1541-7786.MCR-07-0267 18171984
19. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J, PLoS ONE 2010 5 10
20. Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. Lips EH, van Eijk R, de Graaf EJ, Oosting J, de Miranda NF, Karsten T, van de Velde CJ, Eilers PH, Tollenaar RA, van Wezel T, Morreau H, BMC Cancer 2008 8 314 10.1186/1471-2407-8-314 18959792
21. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, Mori M, Clin Cancer Res 2012 18 11 3054 3070 10.1158/1078-0432.CCR-11-1078 22452939
22. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ, Lancet 2007 370 9604 2020 2029 10.1016/S0140-6736(07)61866-2 18083404
23. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A, N Engl J Med 2004 350 23 2343 2351 10.1056/NEJMoa032709 15175436
24. Gene expression profiles in stage II and III colon cancer. Application of a 128-gene signature. Thorsteinsson MKL, Lund LR, Sørensen LT, Gerds TA, Jess P, Olsen J, Int J Colorectal Dis 2012 27 12 1579 1586 10.1007/s00384-012- 1517-4 22710688
25. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD, Gastroenterology 2010 138 3 958 968 10.1053/j.gastro.2009.11.005 19914252
26. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, Hinzmann B, Castanos-Velez E, Pilarsky C, Mann B, Brümmendorf T, Weber B, Buhr HJ, Rosenthal A, J Mol Med (Berl) 2009 87 6 633 644 10.1007/s00109-009-0467-y 19399471
27. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, Rodermond H, Dekker E, van der Loos CM, Pals ST, van de Vijver MJ, Versteeg R, Richel DJ, Vermeulen L, Medema JP, Cell Stem Cell 2011 9 5 476 485 10.1016/j.stem.2011.10.008 22056143
28. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, Costa A, Leo E, Pilotti S, Pierotti MA, Genes Chromosomes Cancer 2009 48 11 953 962 10.1002/gcc.20697 19672874
29. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, et al. Genome Biol 2007 8 7 131 10.1186/gb-2007-8-7-r131 17615082
30. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S, N Engl J Med 2000 342 2 69 77 10.1056/ NEJM200001133420201 10631274
31. DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers. Jorissen RN, Lipton L, Gibbs P, Chapman M, Desai J, Jones IT, Yeatman TJ, East P, Tomlinson IP, Verspaget HW, Aaltonen LA, Kruhøffer M, Orntoft TF, Andersen CL, Sieber OM, Clin Cancer Res 2008 14 24 8061 8069 10.1158/1078-0432.CCR-08-1431 19088021
32. Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis. Earl TM, Nicoud IB, Pierce JM, Wright JP, Majoras NE, Rubin JE, Pierre KP, Gorden DL, Chari RS, Ann Surg Oncol 2009 16 4 1043 1050 10.1245/s10434-009-0325-8 19165543
33. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X, J Exp Clin Cancer Res 2010 29 92 10.1186/1756-9966-29-92 20618976
34. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R, Kirkpatrick CJ, Int J Mol Med 2007 20 1 21 29 17549384
35. Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Adegboyega PA, Mifflin RC, DiMari JF, Saada JI, Powell DW, Arch Pathol Lab Med 2002 126 7 829 836 12088453
36. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Adegboyega PA, Ololade O, Saada J, Mifflin R, di Mari JF, Powell DW, Clin Cancer Res 2004 10 17 5870 5879 10.1158/1078-0432.CCR-0431-03 15355919
37. Fibroblasts in cancer. Kalluri R, Zeisberg M, Nat Rev Cancer 2006 6 5 392 401 10.1038/nrc1877 16572188
38. Immunohistochemical study of myofibroblasts in colorectal epithelial lesions. Ban S, Mitsuhashi T, Shimizu M, Arch Pathol Lab Med 2003 127 12 1551 1553 author reply 1551-1552 14655255
39. Stromal fibroblasts in digestive cancer. Worthley DL, Giraud AS, Wang TC, Cancer Microenviron 2010 3 1 117 125 10.1007/s12307-009-0033-8 21209778
40. Intestinal myofibroblasts in innate immune responses of the intestine. Otte JM, Rosenberg IM, Podolsky DK, Gastroenterology 2003 124 7 1866 1878 10.1016/S0016-5085(03)00403-7 12806620
41. University of California Santa Clara genome browser. http://genome.ucsc. edu/cgi-bin/hgTracks?hgHubConnect.destUrl=.%2Fcgi-bin%2FhgTracks&clade= mammal&org=Human&db=hg19&position=chr9%3A120466460- 120479766&hgt.suggest=tlr4&hgt.suggestTrack=knownGene&Submit= submit&hgsid=279196009&knownGene=pack
42. Consequences of regulated pre-mRNA splicing in the immune system. Lynch KW, Nat Rev Immunol 2004 4 12 931 940 10.1038/nri1497 15573128
43. Alternate transcription of the Toll-like receptor signaling cascade. Wells CA, Chalk AM, Forrest A, Taylor D, Waddell N, Schroder K, Himes SR, Faulkner G, Lo S, Kasukawa T, Kawaji H, Kai C, Kawai J, Katayama S, Carninci P, Hayashizaki Y, Hume DA, Grimmond SM, Genome Biol 2006 7 2 10 10.1186/gb-2006-7-2-r10 16507160
44. Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes. Grigoryev YA, Kurian SM, Nakorchevskiy AA, Burke JP, Campbell D, Head SR, Deng J, Kantor AB, Yates JR 3rd, Salomon DR, PLoS ONE 2009 4 11 7906 10.1371/journal.pone.0007906 19936255
45. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer. Moon JW, Lee SK, Lee JO, Kim N, Lee YW, Kim SJ, Kang HJ, Kim J, Kim HS, Park SH, J Exp Clin Cancer Res 2014 33 4 10.1186/1756-9966-33-4 24393480
46. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA, Nat Immunol 2010 11 2 141 147 10.1038/ni.1828 19946272